The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2014LRRK2 Expression in Postmortem Brain
Objective/Rationale:
Mutations in LRRK2 are a major genetic cause of Parkinson’s disease. This study aims to determine what happens to the amount of LRRK2 protein in the brains of people with Parkinson... -
Neurotrophic Factors Challenge, 2014Delivery of Cerebral Dopamine Neurotrophic Factor with Microbubbles and MRI-guided Focused Ultrasound
Objective/Rationale:
Neurotrophic drugs regenerate and protect brain cells damaged by Parkinson’s disease, but can’t penetrate the blood brain barrier (BBB). With direct needle or catheter drug... -
Research Grant, 2014Identification of Small Molecule Activators of Parkin Protein
Objective/Rationale:
Loss of parkin protein in humans leads to loss of dopamine neurons and ultimately Parkinson’s disease (PD). Loss of parkin activity is linked to young-onset familial PD, as well as... -
Research Grant Supplement, 2014PERK Signaling in Parkinson’s Disease Progression
Promising Outcomes of Original Grant:
The original study validated the role of PERK (protein kinase RNA-like endoplasmic reticulum kinase) signaling in the progression of Parkinson’s disease (PD). We... -
Rapid Response Innovation Awards, 2014Optogenetics-based, Photo-switchable Model of Parkinson’s Disease for Drug Screening
Objective/Rationale:
Neurodegeneration has proven notoriously difficult to study. The main barrier to progress has been the challenging, heterogeneous nature of brain tissue. Optogenetics is a... -
Research Grant Supplement, 2014GluN2D Antagonism in the Subthalamic Nucleus for the Treatment of Parkinsonism
Promising Outcomes of Original Grant:
The goal of the original grant was to identify new chemical compounds that block specific types of receptors for the neurotransmitter glutamate and test whether...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.